NewsBenzingaBMO Capital belässt Integra Lifesciences auf „Market Perform“ und senkt das Kursziel auf 15 $ BMO Capital belässt Integra Lifesciences auf „Market Perform“ und senkt das Kursziel auf 15 $ Benzinga 2026.10.05 12:58 (GMT+0) Open on Benzinga Other news American Electric Power Raises Quarterly Dividend From $0.95 To $0.97 Per Share DA Davidson Maintains Buy on Zions Bancorp, Raises Price Target to $80 If You Invested $1000 In TechnipFMC Stock 5 Years Ago, You Would Have This Much Today Analysts Eye $3 Billion Ad Revenue Surge Ahead of Netflix Earnings Northrop Grumman Q3 2026 Earnings Call Transcript Six Years Late, Boeing's Biggest 737 MAX May Finally Be Cleared for Takeoff
